113 related articles for article (PubMed ID: 37831576)
1. Modeling Doxorubicin Pharmacokinetics in Multiple Myeloma Suggests Mechanism of Drug Resistance.
Doshmanziari R; Da Ros F; Mazzucato M; Pedersen MG; Visentin R
IEEE Trans Biomed Eng; 2024 Mar; 71(3):967-976. PubMed ID: 37831576
[TBL] [Abstract][Full Text] [Related]
2. Modeling Pharmacokinetics of Doxorubicin in Multiple Myeloma Cells.
Giaretta A; Da Ros F; Mazzucato M; Pedersen MG; Visentin R
Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():4374-4378. PubMed ID: 34892189
[TBL] [Abstract][Full Text] [Related]
3. Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP.
Baudry E; Huguet S; Couderc AL; Chaibi P; Bret F; Verny C; Weill S; Madar O; Urien S; Rezai K
Cancer Chemother Pharmacol; 2019 Apr; 83(4):775-785. PubMed ID: 30689002
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.
Anders CK; Adamo B; Karginova O; Deal AM; Rawal S; Darr D; Schorzman A; Santos C; Bash R; Kafri T; Carey L; Miller CR; Perou CM; Sharpless N; Zamboni WC
PLoS One; 2013; 8(5):e61359. PubMed ID: 23650496
[TBL] [Abstract][Full Text] [Related]
6. Alpha-tocopheryl succinate enhances doxorubicin-induced apoptosis in human gastric cancer cells via promotion of doxorubicin influx and suppression of doxorubicin efflux.
Zhang X; Peng X; Yu W; Hou S; Zhao Y; Zhang Z; Huang X; Wu K
Cancer Lett; 2011 Aug; 307(2):174-81. PubMed ID: 21536373
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of drug-resistant human ovarian tumor cell lines to combined effects of tumor necrosis factor (TNF-alpha) and doxorubicin: failure of the combination to modulate the MDR phenotype.
Safrit JT; Berek JS; Bonavida B
Gynecol Oncol; 1993 Feb; 48(2):214-20. PubMed ID: 8428693
[TBL] [Abstract][Full Text] [Related]
8.
Cornillie J; Wozniak A; Pokreisz P; Casazza A; Vreys L; Wellens J; Vanleeuw U; Gebreyohannes YK; Debiec-Rychter M; Sciot R; Hompes D; Schöffski P
Mol Cancer Ther; 2017 Aug; 16(8):1566-1575. PubMed ID: 28566438
[TBL] [Abstract][Full Text] [Related]
9. Naked and Decorated Nanoparticles Containing H
Peira E; Chirio D; Sapino S; Chegaev K; Chindamo G; Salaroglio IC; Riganti C; Gallarate M
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232858
[TBL] [Abstract][Full Text] [Related]
10. Understanding doxorubicin associated calcium remodeling during triple-negative breast cancer treatment: an
Arora G; Ghosh S; Chatterjee S
Explor Target Antitumor Ther; 2021; 2(2):208-226. PubMed ID: 36046147
[TBL] [Abstract][Full Text] [Related]
11. Ovatodiolide sensitizes aggressive breast cancer cells to doxorubicin, eliminates their cancer stem cell-like phenotype, and reduces doxorubicin-associated toxicity.
Bamodu OA; Huang WC; Tzeng DT; Wu A; Wang LS; Yeh CT; Chao TY
Cancer Lett; 2015 Aug; 364(2):125-34. PubMed ID: 25976769
[TBL] [Abstract][Full Text] [Related]
12. Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy.
Tang L; Tong R; Coyle VJ; Yin Q; Pondenis H; Borst LB; Cheng J; Fan TM
ACS Nano; 2015 May; 9(5):5072-81. PubMed ID: 25938427
[TBL] [Abstract][Full Text] [Related]
13. Targeted Drug Delivery Biopolymers Effectively Inhibit Breast Tumor Growth and Prevent Doxorubicin-Induced Cardiotoxicity.
Dragojevic S; Ryu JS; Hall ME; Raucher D
Molecules; 2022 May; 27(11):. PubMed ID: 35684309
[TBL] [Abstract][Full Text] [Related]
14. Modulation of multidrug resistance p-glycoprotein activity by flavonoids and honokiol in human doxorubicin- resistant sarcoma cells (MES-SA/DX-5): implications for natural sedatives as chemosensitizing agents in cancer therapy.
Angelini A; Di Ilio C; Castellani ML; Conti P; Cuccurullo F
J Biol Regul Homeost Agents; 2010; 24(2):197-205. PubMed ID: 20487633
[TBL] [Abstract][Full Text] [Related]
15. Modulatory effects of heparin on cellular accumulation and cytotoxicity of doxorubicin in MRP1-overexpressing HL60/doxo cells.
Angelini A; Ciofani G; Baccante G; Di Febbo C; Carmine DI; Cuccurullo F; Porreca E
Anticancer Res; 2007; 27(1A):351-5. PubMed ID: 17352253
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P-glycoprotein-mediated multidrug resistance by unfractionated heparin: a new potential chemosensitizer for cancer therapy.
Angelini A; Di Febbo C; Ciofani G; Di Nisio M; Baccante G; Di Ilio C; Cuccurullo F; Porreca E
Cancer Biol Ther; 2005 Mar; 4(3):313-7. PubMed ID: 15876859
[TBL] [Abstract][Full Text] [Related]
17. BBB opening by low pulsed electric fields, depicted by delayed-contrast MRI, enables efficient delivery of therapeutic doxorubicin doses into mice brains.
Cooper I; Last D; Ravid O; Rand D; Matsree E; Omesi L; Shemesh C; Liberman M; Zach L; Furman O; Daniels D; Liraz-Zaltsman S; Mardor Y; Sharabi S
Fluids Barriers CNS; 2023 Sep; 20(1):67. PubMed ID: 37737197
[TBL] [Abstract][Full Text] [Related]
18. Effects of doxorubicin associated with amniotic membrane stem cells in the treatment of canine inflammatory breast carcinoma (IPC-366) cells.
Borghesi J; Caceres S; Mario LC; Alonso-Diez A; Silveira Rabelo AC; Illera MJ; Silvan G; Miglino MA; Favaron PO; Carreira ACO; Illera JC
BMC Vet Res; 2020 Sep; 16(1):353. PubMed ID: 32972410
[TBL] [Abstract][Full Text] [Related]
19. MDR1 modulators improve the chemotherapy response of human hepatoblastoma to doxorubicin in vitro.
Warmann S; Göhring G; Teichmann B; Geerlings H; Fuchs J
J Pediatr Surg; 2002 Nov; 37(11):1579-84. PubMed ID: 12407543
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive delivery of doxorubicin from citrate-apatite nanocrystals with tailored carbonate content.
Rodríguez-Ruiz I; Delgado-López JM; Durán-Olivencia MA; Iafisco M; Tampieri A; Colangelo D; Prat M; Gómez-Morales J
Langmuir; 2013 Jul; 29(26):8213-21. PubMed ID: 23735159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]